KLRA (KLRA) Stock Price & Analysis
KLRA (KLRA) rose 3.11% to USD 16.23 as of September 8, 2026 at 09:08 UTC, according to Nexqual real-time market data.
KLRA last closed at USD 16.23; the session ranged USD 15.6–16.44 on volume of 524,423 shares. Market capitalization is —, with a 52-week range of USD 15.15–28.23 (NMS). Source: Nexqual, September 8, 2026 at 09:08 UTC.
Key Statistics (as of September 8, 2026 at 09:08 UTC)
| Price | USD 16.23 |
|---|---|
| Change | ▲ 3.11% (up) |
| Previous Close | USD 16.23 |
| Open | USD 16.23 |
| Day Range | USD 15.6 – 16.44 |
| 52-Week Range | USD 15.15 – 28.23 |
| Volume | 524,423 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (KLRA)
Nexqual's technical model rates KLRA "STRONG SELL" based on 0 bullish and 5 bearish signals across 98 daily candles, as of September 8, 2026 at 09:08 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 42.65 (neutral) |
| vs SMA50 | Below (USD 18.51) |
| MACD | -0.68 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COAG | Hemab Therapeutics Holdings, In | USD 44.41 | ▼ 0.65% |
| PBLS | Parabilis Medicines, Inc. | USD 40.42 | ▲ 0.77% |
| SPTX | Seaport Therapeutics, Inc. | USD 24.86 | ▼ 0.2% |
| MANE | Veradermics, Incorporated | USD 98.51 | ▲ 0.05% |
| AVLN | Avalyn Pharma Inc. | USD 37.39 | ▲ 5.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:08 UTC. This page is informational and not investment advice.